ekonominyheter

TranslateRSSMobil
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015

Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015

Fool.com 17/11 10:13

Johnson & Johnson has had a great year largely because of its hepatitis C drug Olysio. This top dividend stock, though, might reverse course in 2015. Here's why.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status